Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-08 11:50 am Sale | 2022-11-30 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 4,225,908 4.860% | -368,667 (-8.02%) | Filing History |
| 2022-08-12 06:44 am Purchase | 2022-06-16 | 13D | Wave Life Sciences Ltd. WVE | Shin Nippon Biomedical Laboratories Ltd. | 9,666,408 10.600% | 3,771,930 (+63.99%) | Filing History |
| 2022-07-20 06:08 am Sale | 2020-09-22 | 13D | Wave Life Sciences Ltd. WVE | Kagoshima Shinsangyo Sousei Investment Limited Partnership | 2,019,873 3.300% | -115,101 (-5.39%) | Filing History |
| 2022-06-21 4:35 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 17,269,811 19.990% | 9,441,354 (+120.60%) | Filing History |
| 2022-05-26 4:44 pm Purchase | 2022-05-16 | 13G | Wave Life Sciences Ltd. WVE | 683 Capital Management LLC | 3,630,425 5.900% | 3,630,425 (New Position) | Filing History |
| 2022-02-14 3:07 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | MAVERICK CAPITAL LTD | 5,593,389 9.500% | 5,593,389 (New Position) | Filing History |
| 2022-02-14 08:27 am Sale | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | Nantahala Capital Management, LLC | 907,094 1.500% | -2,450,211 (-72.98%) | Filing History |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 4,602,858 7.800% | 2,000,000 (+76.84%) | Filing History |
| 2022-02-11 4:18 pm Sale | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | James E. Flynn | 552,690 0.940% | -3,357,740 (-85.87%) | Filing History |
| 2022-02-11 4:06 pm Unchanged | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | PFIZER INC PFE | 1,875,000 3.190% | 0 (Unchanged) | Filing History |
| 2022-02-10 12:29 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 4,594,575 7.810% | 670,100 (+17.07%) | Filing History |
| 2021-12-10 10:05 am Sale | 2021-11-30 | 13G | Wave Life Sciences Ltd. WVE | BlackRock Inc. BLK | 2,863,620 4.900% | -161,584 (-5.34%) | Filing |
| 2021-11-12 4:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 7,828,457 13.300% | 5,250 (+0.07%) | Filing History |
| 2021-10-29 11:37 am Purchase | 2021-10-27 | 13G | Wave Life Sciences Ltd. WVE | M28 Capital Management LP | 3,765,588 7.200% | 3,765,588 (New Position) | Filing History |
| 2021-08-18 5:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 7,823,207 15.390% | 48,000 (+0.62%) | Filing History |
| 2021-04-09 1:19 pm Purchase | 2021-03-30 | 13G | Wave Life Sciences Ltd. WVE | James E. Flynn | 3,910,430 7.980% | 3,910,430 (New Position) | Filing History |
| 2021-02-16 4:09 pm Sale | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | Redmile Group, LLC | 79,018 0.200% | -3,247,475 (-97.62%) | Filing History |
| 2021-02-16 10:23 am Purchase | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | Nantahala Capital Management, LLC | 3,357,305 6.900% | 3,357,305 (New Position) | Filing History |
| 2021-02-12 4:48 pm Purchase | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 2,602,858 5.300% | 200,000 (+8.32%) | Filing History |
| 2021-02-12 12:02 pm Purchase | 2009-02-28 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO/CA/ | 3,924,475 8.050% | 3,924,475 (New Position) | Filing History |